BioSpace News Archive

Akero Therapeutics, Inc. (Nasdaq: AKRO) today announced the presentation of additional data analysis from the Phase 2a BALANCED study at the Presidential Oral Plenary Session at The Liver Meeting®.

Xenetic Biosciences, Inc. a personalized CAR T platform technology engineered to target patient- and tumor-specific neoantigens, reported its financial results for the three and nine months ended September 30, 2020 and provided a corporate update.

OtoNexus Medical Technologies has been selected as a finalist for Red Herring’s Top 100 North America award, one of the technology industry’s most prestigious prizes.

Cybin Inc. (NEO: CYBN) announces the availability of a broadcast titled, “On the Trail of Better Therapeutics for Depression.

Greenwich Biosciences, U.S. subsidiary of GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), a world leader in the science, development, and commercialization of cannabinoid prescription medicines, will present data from an analysis of three Phase 3 clinical trials of nabiximols in spasticity among persons with multiple sclerosis (MS) at the American Academy of Physical Medicine and Rehabilitation (AAPM&R) Virtual Annual Assembly

Heron Therapeutics, Inc. (Nasdaq: HRTX), today announced that the New Drug Application (NDA) was resubmitted to the U.S. Food and Drug Administration (FDA) for HTX-011, an investigational agent for the management of postoperative pain.

Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc., and EXINI Diagnostics AB, and a global leader in the development, manufacture and commercialization of innovative diagnostic and therapeutic agents and products, announced the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the use of Lantheus’ artificial intelligence e

Readout Health, a digital biomarker startup, announced today its partnership with Apollo Health, a health technology leader in neurodegenerative medicine. Apollo Health has created the first online community of specially trained healthcare practitioners and participants partnering to use a science-based protocol demonstrated to prevent and reverse cognitive decline.

China Jo-Jo Drugstores, Inc., a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, announced its financial results for the second fiscal quarter ended September 30, 2020.

ExeGi Pharma LLC, a company focused on developing live biotherapeutic (“LBP”) drugs and probiotics, announced today that its biologic drug candidate, EXE-346, has received an orphan drug designation from the U.S. Food and Drug Administration (FDA) for the prevention of disease relapse in pouchitis.